https://news.medxy.ai/zh/left-atrial-volume-index-2/Medxy AIzh2026-08-12T10:49:58-07:00移植前左心房容积指数：预测肾移植后1年发病风险的新线索 https://news.medxy.ai/vi/left-atrial-volume-index/Medxy AIvi2026-08-12T10:49:13-07:00Chỉ số thể tích nhĩ trái trước ghép: Dấu ấn dự báo bệnh suất 1 năm sau ghép thận https://news.medxy.ai/pre-transplant-left-atrial-volume-index-as-a-predictor-of-one-year-morbidity-after-kidney-transplantation-insights-and-implications/Medxy AIen2026-08-12T10:47:07-07:00Pre-Transplant Left Atrial Volume Index as a Predictor of One-Year Morbidity after Kidney Transplantation: Insights and Implications https://news.medxy.ai/ja/donor-pancreas-transplant/Medxy AIja2026-08-12T10:46:22-07:00循環死後ドナー膵・膵島移植を変える常温区域灌流の可能性 https://news.medxy.ai/vi/body-circulation-physiology/Medxy AIvi2026-08-12T10:45:57-07:00Tuần hoàn vùng cơ thể ở nhiệt độ sinh lý: Bước ngoặt trong ghép tụy và ghép tiểu đảo tụy từ người hiến DCD https://news.medxy.ai/normothermic-regional-perfusion-a-paradigm-shift-in-pancreas-and-islet-transplantation-from-dcd-donors/Medxy AIen2026-08-12T10:45:01-07:00Normothermic Regional Perfusion: A Paradigm Shift in Pancreas and Islet Transplantation from DCD Donors https://news.medxy.ai/vi/pyoderma-gangrenosum-classification/Medxy AIvi2026-08-12T10:44:05-07:00Pyoderma gangrenosum: Khung phân loại thực hành từ đồng thuận chuyên gia https://news.medxy.ai/a-practical-framework-for-pyoderma-gangrenosum-expert-consensus-defines-phenotypes-and-modifiers/Medxy AIen2026-08-12T10:40:15-07:00A Practical Framework for Pyoderma Gangrenosum: Expert Consensus Defines Phenotypes and Modifiers https://news.medxy.ai/zh/confocal-microscopy-prediction/Medxy AIzh2026-08-12T10:39:57-07:00反射式共聚焦显微镜与深度学习助力面部特应性皮炎患者度普利尤单抗疗效的早期预测 https://news.medxy.ai/ja/dupilumab-effect-prediction/Medxy AIja2026-08-12T10:39:39-07:00反射型共焦点顕微鏡と深層学習による顔面アトピー性皮膚炎におけるデュピルマブ効果の早期予測 https://news.medxy.ai/vi/early-dupilumab-prediction/Medxy AIvi2026-08-12T10:39:19-07:00Dự đoán sớm hiệu quả của dupilumab trong viêm da cơ địa vùng mặt bằng kính hiển vi đồng tiêu phản xạ và học sâu https://news.medxy.ai/early-prediction-of-dupilumab-efficacy-in-facial-atopic-dermatitis-via-reflectance-confocal-microscopy-and-deep-learning/Medxy AIen2026-08-12T10:38:31-07:00Early Prediction of Dupilumab Efficacy in Facial Atopic Dermatitis via Reflectance Confocal Microscopy and Deep Learning https://news.medxy.ai/zh/breast-augmentation-analysis-2/Medxy AIzh2026-08-12T10:38:13-07:00组织保留与三维几何分析优化隆胸：临床要点与结局 https://news.medxy.ai/ja/breast-augmentation-analysis/Medxy AIja2026-08-12T10:37:55-07:00組織温存と3D幾何解析で磨く乳房増大術：臨床知見とその成果 https://news.medxy.ai/vi/breast-augmentation-3d-analysis/Medxy AIvi2026-08-12T10:37:25-07:00Nâng ngực tối ưu hóa nhờ bảo tồn mô và phân tích hình học 3D: góc nhìn lâm sàng và kết quả https://news.medxy.ai/optimizing-breast-augmentation-through-tissue-preservation-and-3d-geometric-analysis-clinical-insights-and-outcomes/Medxy AIen2026-08-12T10:36:13-07:00Optimizing Breast Augmentation Through Tissue Preservation and 3D Geometric Analysis: Clinical Insights and Outcomes https://news.medxy.ai/zh/botox-strategy-optimization/Medxy AIzh2026-08-12T10:35:53-07:00优化口角上提的肉毒毒素注射策略：一项严格两阶段随机试验的启示 https://news.medxy.ai/ja/botulinum-toxin-optimization-2/Medxy AIja2026-08-12T10:35:33-07:00口角挙上を最適化するボツリヌス毒素注射：厳密な2段階ランダム化試験から得られた知見 https://news.medxy.ai/vi/botulinum-toxin-optimization/Medxy AIvi2026-08-12T10:35:15-07:00Tối ưu hóa tiêm Botulinum toxin để nâng khóe miệng: Những phát hiện từ một thử nghiệm ngẫu nhiên hai giai đoạn nghiêm ngặt https://news.medxy.ai/optimizing-botulinum-toxin-injections-for-oral-commissure-elevation-insights-from-a-rigorous-two-stage-randomized-trial/Medxy AIen2026-08-12T10:34:01-07:00Optimizing Botulinum Toxin Injections for Oral Commissure Elevation: Insights from a Rigorous Two-Stage Randomized Trial https://news.medxy.ai/zh/childhood-trauma-bipolar-2/Medxy AIzh2026-08-12T10:33:40-07:00揭示儿童期创伤与躁郁症之间的神经生物学通路：来自 ENIGMA 联盟的研究见解 https://news.medxy.ai/vi/childhood-trauma-bipolar/Medxy AIvi2026-08-12T10:32:55-07:00Giải mã các con đường thần kinh sinh học nối sang chấn thời thơ ấu với rối loạn lưỡng cực: Góc nhìn từ ENIGMA Consortium https://news.medxy.ai/unraveling-the-neurobiological-pathways-linking-childhood-trauma-to-bipolar-disorder-insights-from-the-enigma-consortium/Medxy AIen2026-08-12T10:31:47-07:00Unraveling the Neurobiological Pathways Linking Childhood Trauma to Bipolar Disorder: Insights from the ENIGMA Consortium https://news.medxy.ai/zh/vasopressin-timing-sepsis/Medxy AIzh2026-08-12T10:31:30-07:00脓毒性休克中去甲肾上腺素升级后：超早期启动加压素是否优于早期启动？来自目标试验模拟的启示 https://news.medxy.ai/ja/vasopressin-sepsis-shock/Medxy AIja2026-08-12T10:31:12-07:00敗血症性ショックにおけるノルアドレナリン増量後のバソプレシン早期導入：ターゲットトライアル・エミュレーションからの知見 https://news.medxy.ai/vi/early-vasopressin-treatment/Medxy AIvi2026-08-12T10:30:52-07:00Khởi trị vasopressin siêu sớm sau khi tăng norepinephrine trong sốc nhiễm khuẩn: bằng chứng từ mô phỏng thử nghiệm mục tiêu https://news.medxy.ai/ultra-early-versus-early-vasopressin-initiation-after-norepinephrine-escalation-in-septic-shock-insights-from-a-target-trial-emulation/Medxy AIen2026-08-12T10:29:46-07:00Ultra-Early Versus Early Vasopressin Initiation After Norepinephrine Escalation in Septic Shock: Insights from a Target Trial Emulation https://news.medxy.ai/zh/icu-rrt-benefits-risks/Medxy AIzh2026-08-12T10:29:28-07:00ICU重症患者RRT的获益与风险：日本登记研究揭示治疗效应的复杂异质性 https://news.medxy.ai/ja/icu-renal-therapy-benefits-risks/Medxy AIja2026-08-12T10:29:10-07:00ICU重症患者における腎代替療法の利益とリスクを読み解く：日本レジストリからの知見 https://news.medxy.ai/vi/kidney-replacement-icu/Medxy AIvi2026-08-12T10:28:49-07:00Làm rõ lợi ích và nguy cơ phức tạp của liệu pháp thay thế thận ở bệnh nhân ICU: Góc nhìn từ một cơ sở đăng ký của Nhật Bản https://news.medxy.ai/unraveling-the-complex-benefits-and-risks-of-renal-replacement-therapy-in-icu-patients-insights-from-a-japanese-registry/Medxy AIen2026-08-12T10:28:00-07:00Unraveling the Complex Benefits and Risks of Renal Replacement Therapy in ICU Patients: Insights from a Japanese Registry https://news.medxy.ai/zh/empowering-internal-medicine-residents/Medxy AIzh2026-08-12T10:27:42-07:00赋能内科住院医师应对肥胖：资源不足城市门诊中的综合培训路径 https://news.medxy.ai/ja/obesity-care-clinic/Medxy AIja2026-08-12T10:27:23-07:00都市部の十分な医療資源が行き届きにくい診療所で進める肥満症対策：総合内科レジデント育成の包括的研修パス https://news.medxy.ai/vi/empowering-resident-physicians/Medxy AIvi2026-08-12T10:26:59-07:00Trao quyền cho bác sĩ nội trú nội khoa trong cuộc chiến chống béo phì: một lộ trình đào tạo toàn diện tại phòng khám đô thị thiếu nguồn lực https://news.medxy.ai/empowering-internal-medicine-residents-to-combat-obesity-a-comprehensive-training-pathway-in-an-underserved-urban-clinic/Medxy AIen2026-08-12T10:25:57-07:00Empowering Internal Medicine Residents to Combat Obesity: A Comprehensive Training Pathway in an Underserved Urban Clinic https://news.medxy.ai/zh/lung-cancer-screening-2/Medxy AIzh2026-08-12T10:25:40-07:00提升肺癌筛查依从性：来自健康沟通与分层提醒干预随机临床试验的启示 https://news.medxy.ai/ja/lung-cancer-screening/Medxy AIja2026-08-12T10:25:19-07:00肺がん検診の受診継続率を高めるには：健康コミュニケーションと段階的リマインダー介入のランダム化試験から得られた知見 https://news.medxy.ai/enhancing-lung-cancer-screening-adherence-insights-from-a-randomized-clinical-trial-of-health-communication-and-stepped-reminder-interventions/Medxy AIen2026-08-12T10:23:21-07:00Enhancing Lung Cancer Screening Adherence: Insights from a Randomized Clinical Trial of Health Communication and Stepped Reminder Interventions https://news.medxy.ai/zh/hallux-rigidus-surgery/Medxy AIzh2026-08-12T10:23:02-07:00拇趾僵硬症：手术融合术优于观察等待吗？——一项里程碑式随机对照试验的启示 https://news.medxy.ai/vi/arthrodesis-vs-waiting/Medxy AIvi2026-08-12T10:22:23-07:00Arthrodesis phẫu thuật hay theo dõi chờ đợi trong hallux rigidus: Góc nhìn từ một thử nghiệm ngẫu nhiên có đối chứng mang tính bước ngoặt https://news.medxy.ai/surgical-arthrodesis-versus-watchful-waiting-in-hallux-rigidus-insights-from-a-landmark-randomized-controlled-trial/Medxy AIen2026-08-12T10:21:38-07:00Surgical Arthrodesis Versus Watchful Waiting in Hallux Rigidus: Insights from a Landmark Randomized Controlled Trial https://news.medxy.ai/zh/sos-vod-incidence-risk-factors/Medxy AIzh2026-08-12T10:21:17-07:00成人异基因HSCT后SOS/VOD的真实世界发生率、危险因素与生物标志物验证：来自西班牙GETH-TC登记的证据 https://news.medxy.ai/vi/sos-vod-incidence-risk/Medxy AIvi2026-08-12T10:20:36-07:00Tỷ lệ mắc thực tế, yếu tố nguy cơ và xác thực dấu ấn sinh học SOS/VOD sau ghép đồng loài ở người lớn: Dữ liệu từ cơ sở đăng ký GETH-TC của Tây Ban Nha https://news.medxy.ai/real-world-incidence-risk-factors-and-biomarker-validation-for-sos-vod-after-allogeneic-hsct-in-adults-insights-from-the-spanish-geth-tc-registry/Medxy AIen2026-08-12T10:19:45-07:00Real-World Incidence, Risk Factors, and Biomarker Validation for SOS/VOD After Allogeneic HSCT in Adults: Insights from the Spanish GETH-TC Registry https://news.medxy.ai/zh/lenalidomide-azacitidine-radiotherapy/Medxy AIzh2026-08-12T10:19:23-07:00来那度胺与口服阿扎胞苷联合放疗治疗浆细胞瘤：一项先导试验及展望 https://news.medxy.ai/ja/lenalidomide-azacitidine-radiation/Medxy AIja2026-08-12T10:19:05-07:00形質細胞腫に対するレナリドミドと経口アザシチジン併用放射線治療：パイロット試験と今後の展望 https://news.medxy.ai/lenalidomide-and-oral-azacitidine-combined-with-radiotherapy-in-plasmacytoma-a-pilot-trial-and-perspectives/Medxy AIen2026-08-12T10:16:23-07:00Lenalidomide and Oral Azacitidine Combined with Radiotherapy in Plasmacytoma: A Pilot Trial and Perspectives https://news.medxy.ai/zh/usp8-b-cell-myeloma/Medxy AIzh2026-08-12T10:16:03-07:00USP8：B 细胞蛋白稳态与多发性骨髓瘤耐药的新靶点 https://news.medxy.ai/ja/b-cell-proteostasis-myeloma/Medxy AIja2026-08-12T10:15:45-07:00USP8を標的としたB細胞プロテオスタシスと多発性骨髄腫耐性の克服 https://news.medxy.ai/vi/usp8-potential-target/Medxy AIvi2026-08-12T10:15:24-07:00USP8: Đích điều trị tiềm năng trong proteostasis tế bào B và kháng đa u tủy https://news.medxy.ai/usp8-as-a-therapeutic-target-in-b-cell-proteostasis-and-multiple-myeloma-resistance/Medxy AIen2026-08-12T10:13:17-07:00USP8 as a Therapeutic Target in B Cell Proteostasis and Multiple Myeloma Resistance https://news.medxy.ai/zh/l-carnitine-regulation/Medxy AIzh2026-08-12T10:02:25-07:00l-肉碱调控人造血干/祖细胞再生的代谢机制：作用解析与治疗启示 https://news.medxy.ai/ja/l-carnitine-hematopoiesis/Medxy AIja2026-08-12T10:02:09-07:00l-カルニチンが切り開くヒト造血幹・前駆細胞再生の代謝制御：機序的洞察と治療応用 https://news.medxy.ai/vi/l-carnitine-metabolism/Medxy AIvi2026-08-12T10:01:49-07:00l-Carnitine điều hòa chuyển hóa trong tái sinh tế bào gốc và tiền thân tạo máu ở người: cơ chế và ý nghĩa điều trị https://news.medxy.ai/metabolic-regulation-of-human-hematopoietic-stem-and-progenitor-cell-regeneration-by-l-carnitine-mechanistic-insights-and-therapeutic-implications/Medxy AIen2026-08-12T10:00:19-07:00Metabolic Regulation of Human Hematopoietic Stem and Progenitor Cell Regeneration by l-Carnitine: Mechanistic Insights and Therapeutic Implications https://news.medxy.ai/zh/copd-beta-blocker-benefit/Medxy AIzh2026-08-12T09:59:50-07:00COPD合并心血管疾病患者使用β受体阻滞剂的生存获益：LABA联用的影响 https://news.medxy.ai/ja/beta-blockers-copd-cvd/Medxy AIja2026-08-12T09:59:33-07:00COPD合併心血管疾患におけるβ遮断薬の死亡率改善効果を読み解く：LABA併用の影響 https://news.medxy.ai/vi/beta-blockers-copd-benefits/Medxy AIvi2026-08-12T09:59:15-07:00Làm rõ lợi ích sống còn của thuốc chẹn beta ở bệnh nhân COPD có bệnh tim mạch: Ảnh hưởng của điều trị phối hợp LABA https://news.medxy.ai/unraveling-the-mortality-benefits-of-beta-blockers-in-copd-patients-with-cardiovascular-disease-influence-of-laba-co-therapy/Medxy AIen2026-08-12T09:57:46-07:00Unraveling the Mortality Benefits of Beta-Blockers in COPD Patients with Cardiovascular Disease: Influence of LABA Co-therapy https://news.medxy.ai/zh/post-tuberculosis-lung-damage/Medxy AIzh2026-08-12T09:57:25-07:00肺外结核后仍可持续受损：揭示结核后肺疾病的隐匿负担 https://news.medxy.ai/ja/post-tuberculosis-lung-damage-2/Medxy AIja2026-08-12T09:57:04-07:00肺外結核後も続く肺機能障害：見えにくい結核後肺疾患の負担を探る https://news.medxy.ai/vi/post-tb-lung-dysfunction/Medxy AIvi2026-08-12T09:56:41-07:00Rối loạn chức năng phổi kéo dài sau lao ngoài phổi: Làm rõ gánh nặng ẩn của bệnh phổi sau lao https://news.medxy.ai/persistent-lung-dysfunction-after-extra-pulmonary-tuberculosis-unveiling-the-hidden-burden-of-post-tb-lung-disease/Medxy AIen2026-08-12T09:55:29-07:00Persistent Lung Dysfunction After Extra-Pulmonary Tuberculosis: Unveiling the Hidden Burden of Post-TB Lung Disease https://news.medxy.ai/zh/scleral-fixation-iol/Medxy AIzh2026-08-12T09:55:11-07:00Yamane 巩膜内固定中的 IOL 公式屈光结局与预测准确性 https://news.medxy.ai/ja/yamane-iol-calculation/Medxy AIja2026-08-12T09:54:53-07:00Yamane強膜内固定におけるIOL度数計算式の屈折成績と予測精度 https://news.medxy.ai/vi/iol-power-prediction/Medxy AIvi2026-08-12T09:54:33-07:00Kết quả khúc xạ và độ chính xác dự đoán của các công thức tính công suất IOL trong cố định nội củng mạc theo Yamane https://news.medxy.ai/refractive-outcomes-and-predictive-accuracy-of-iol-power-formulas-in-yamane-intrascleral-fixation/Medxy AIen2026-08-12T09:53:18-07:00Refractive Outcomes and Predictive Accuracy of IOL Power Formulas in Yamane Intrascleral Fixation https://news.medxy.ai/ja/dual-focus-glasses-effectiveness/Medxy AIja2026-08-12T09:52:35-07:00小児近視抑制における双面複合デフォーカス眼鏡の有効性と安全性：エビデンスを総覧する https://news.medxy.ai/efficacy-and-safety-of-dual-sided-composite-defocus-spectacles-for-pediatric-myopia-control-a-comprehensive-evidence-review/Medxy AIen2026-08-12T09:50:16-07:00Efficacy and Safety of Dual-Sided Composite Defocus Spectacles for Pediatric Myopia Control: A Comprehensive Evidence Review https://news.medxy.ai/zh/tension-glottoplasty/Medxy AIzh2026-08-12T09:49:55-07:00张力性声门成形术：以生物力学创新推动声音女性化外科进展 https://news.medxy.ai/ja/voice-feminization-surgery/Medxy AIja2026-08-12T09:49:41-07:00張力付加声門形成術：生体力学的革新で切り開く声の女性化手術の新展開 https://news.medxy.ai/vi/tensioning-glottoplasty/Medxy AIvi2026-08-12T09:49:08-07:00Tensioning Glottoplasty: Bước tiến cơ sinh học trong phẫu thuật nữ tính hóa giọng nói https://news.medxy.ai/tensioning-glottoplasty-advancing-surgical-voice-feminization-with-biomechanical-innovation/Medxy AIen2026-08-12T09:47:57-07:00Tensioning Glottoplasty: Advancing Surgical Voice Feminization with Biomechanical Innovation https://news.medxy.ai/zh/robotic-pancreatectomy-assessment/Medxy AIzh2026-08-12T09:47:38-07:00日本全国机器人辅助远端胰切除术治疗恶性肿瘤的评估：安全性、结局与比较效果 https://news.medxy.ai/vi/robotic-distal-pancreatectomy-for-malignancy-safety-outcomes-and-comparative-effectiveness-in-japan/Medxy AIvi2026-08-12T09:47:00-07:00日本における悪性腫瘍に対するロボット支援下膵体尾部切除術の全国的評価：安全性、治療成績、および比較有効性 https://news.medxy.ai/nationwide-evaluation-of-robotic-distal-pancreatectomy-for-malignancy-safety-outcomes-and-comparative-effectiveness-in-japan/Medxy AIen2026-08-12T09:45:46-07:00Nationwide Evaluation of Robotic Distal Pancreatectomy for Malignancy: Safety, Outcomes, and Comparative Effectiveness in Japan https://news.medxy.ai/zh/us-injury-healthcare-analysis/Medxy AIzh2026-08-12T09:45:16-07:00美国伤害医疗支出全景分析：致伤机制、人口学特征与支付方视角 https://news.medxy.ai/ja/us-injury-medical-costs/Medxy AIja2026-08-12T09:44:58-07:00米国の傷害医療費を総覧する：機序、人口学的特性、支払者の視点から https://news.medxy.ai/vi/us-injury-healthcare-spending/Medxy AIvi2026-08-12T09:44:33-07:00Phân tích toàn diện chi tiêu y tế do chấn thương tại Hoa Kỳ: cơ chế, đặc điểm nhân khẩu học và góc nhìn của bên chi trả https://news.medxy.ai/comprehensive-analysis-of-us-health-care-spending-on-injuries-mechanisms-demographics-and-payer-perspectives/Medxy AIen2026-08-12T09:42:46-07:00Comprehensive Analysis of US Health Care Spending on Injuries: Mechanisms, Demographics, and Payer Perspectives https://news.medxy.ai/ja/endometrial-tumor-metabolic-surgery/Medxy AIja2026-08-12T09:42:24-07:00子宮内膜上皮内腫瘍・子宮体がん診療における代謝・肥満外科――SGO–SAGES 共同声明の要点 https://news.medxy.ai/vi/metabolic-bariatric-surgery/Medxy AIvi2026-08-12T09:41:46-07:00Phẫu thuật chuyển hóa và giảm cân trong chăm sóc tân sinh nội biểu mô nội mạc tử cung và ung thư nội mạc tử cung: Hướng dẫn then chốt từ tuyên bố chung SGO–SAGES https://news.medxy.ai/zh/endometrial-cancer-metabolism/Medxy AIzh2026-08-12T09:41:09-07:00子宫内膜上皮内瘤变与子宫内膜癌的代谢与减重手术：SGO–SAGES联合声明要点解读 https://news.medxy.ai/bariatric-surgery-endometrial-cancer/Medxy AIen2026-08-12T09:36:45-07:00Metabolic and Bariatric Surgery in the Care of Endometrial Intraepithelial Neoplasia and Endometrial Cancer: Key Guidance from the SGO–SAGES Joint Statement https://news.medxy.ai/zh/weight-loss-surgery-pregnancy/Medxy AIzh2026-08-12T09:21:22-07:00减重手术、妊娠期糖尿病与围产期结局：来自新南威尔士州大规模人群研究的启示 https://news.medxy.ai/ja/bariatric-surgery-pregnancy/Medxy AIja2026-08-12T09:21:03-07:00肥満手術と妊娠糖尿病は周産期転帰にどう影響するか：ニューサウスウェールズ州の大規模集団研究からの示唆 https://news.medxy.ai/vi/bariatric-surgery-gestational-diabetes/Medxy AIvi2026-08-12T09:20:43-07:00Phẫu thuật béo phì, đái tháo đường thai kỳ và kết cục chu sinh: Phát hiện từ một nghiên cứu quần thể quy mô lớn tại New South Wales https://news.medxy.ai/bariatric-surgery-gestational-diabetes-and-perinatal-outcomes-insights-from-a-large-population-based-study-in-new-south-wales/Medxy AIen2026-08-12T09:19:23-07:00Bariatric Surgery, Gestational Diabetes, and Perinatal Outcomes: Insights from a Large Population-Based Study in New South Wales https://news.medxy.ai/ja/neurodiversity-maternity-care/Medxy AIja2026-08-12T09:18:50-07:00神経多様性に配慮した産科ケア：妊娠・出産に役立つ実践的コミュニケーション戦略 https://news.medxy.ai/vi/neurodiverse-maternity-care/Medxy AIvi2026-08-12T09:18:13-07:00Chăm sóc sản khoa đáp ứng thần kinh đa dạng: Chiến lược giao tiếp thực hành cho thai kỳ và sinh nở https://news.medxy.ai/neurodivergent-responsive-obstetric-care-practical-communication-strategies-for-pregnancy-and-birth/Medxy AIen2026-08-12T09:13:36-07:00Neurodivergent-responsive obstetric care: Practical communication strategies for pregnancy and birth https://news.medxy.ai/ja/cancer-menopause-management/Medxy AIja2026-08-12T09:12:59-07:00がん患者の更年期管理：症状ベース・リスク層別化フレームワーク https://news.medxy.ai/vi/menopause-management-cancer/Medxy AIvi2026-08-12T09:12:14-07:00Quản lý mãn kinh ở bệnh nhân ung thư: Khung thực hành theo triệu chứng và phân tầng nguy cơ https://news.medxy.ai/zh/menopause-management-cancer-2/Medxy AIzh2026-08-12T09:11:34-07:00癌症患者的绝经管理：基于症状与风险分层的实用框架 https://news.medxy.ai/menopause-management/Medxy AIen2026-08-12T09:07:16-07:00Menopause Management in Patients with Cancer: A Symptom‑Based, Risk‑Stratified Framework https://news.medxy.ai/zh/hcc-fontan-liver-disease/Medxy AIzh2026-08-12T09:06:57-07:00解码Fontan相关肝病中的肝细胞癌：基因组与转录组新视角 https://news.medxy.ai/vi/liver-cancer-genomics/Medxy AIvi2026-08-12T09:06:18-07:00Giải mã ung thư biểu mô tế bào gan trong bệnh gan do Fontan: Những phát hiện từ genomic và transcriptomic https://news.medxy.ai/decoding-hepatocellular-carcinoma-in-fontan-associated-liver-disease-genomic-and-transcriptomic-insights/Medxy AIen2026-08-12T09:04:53-07:00Decoding Hepatocellular Carcinoma in Fontan-Associated Liver Disease: Genomic and Transcriptomic Insights https://news.medxy.ai/zh/il-10-antibodies-ibd/Medxy AIzh2026-08-12T09:04:33-07:00IL-10中和性自身抗体与儿童重症炎症性肠病及HLA-DRB1*01:03等位基因相关 https://news.medxy.ai/ja/il-10-autoantibodies/Medxy AIja2026-08-12T09:04:13-07:00IL-10中和自己抗体は重症小児炎症性腸疾患とHLA-DRB1*01:03アレルに関連する https://news.medxy.ai/vi/autoantibodies-il10-ibd/Medxy AIvi2026-08-12T09:03:55-07:00Tự kháng thể trung hòa chống IL-10 liên quan với IBD nhi khoa nặng và alen HLA-DRB1*01:03 https://news.medxy.ai/neutralising-autoantibodies-against-il-10-linked-to-severe-pediatric-inflammatory-bowel-disease-and-hla-drb10103-allele/Medxy AIen2026-08-12T09:02:41-07:00Neutralising Autoantibodies against IL-10 Linked to Severe Pediatric Inflammatory Bowel Disease and HLA-DRB1*01:03 Allele https://news.medxy.ai/zh/deep-learning-mr-perfusion/Medxy AIzh2026-08-12T09:02:22-07:00深度学习驱动的合成 MR 灌注图：急性缺血性卒中影像学的新突破 https://news.medxy.ai/ja/deep-learning-mri-perfusion/Medxy AIja2026-08-12T09:02:03-07:00深層学習で実現する合成MRI灌流マップ：急性虚血性脳卒中画像診断の新たな展開 https://news.medxy.ai/deep-learning-driven-synthetic-mr-perfusion-maps-a-breakthrough-in-acute-ischemic-stroke-imaging/Medxy AIen2026-08-12T08:59:56-07:00Deep Learning-Driven Synthetic MR Perfusion Maps: A Breakthrough in Acute Ischemic Stroke Imaging https://news.medxy.ai/zh/myasthenia-gravis-diagnosis/Medxy AIzh2026-08-12T08:55:48-07:00重症肌无力诊断再提升：细胞基于细胞检测在抗体检出中的优势更明显 https://news.medxy.ai/ja/myasthenia-gravis-diagnosis-3/Medxy AIja2026-08-12T08:55:28-07:00重症筋無力症診断を前進させる：抗体検出における細胞ベースアッセイの優れた精度 https://news.medxy.ai/vi/myasthenia-gravis-diagnosis-2/Medxy AIvi2026-08-12T08:55:07-07:00Nâng cao chẩn đoán bệnh nhược cơ: Xét nghiệm dựa trên tế bào cho độ chính xác vượt trội trong phát hiện kháng thể https://news.medxy.ai/advancing-myasthenia-gravis-diagnosis-the-superior-accuracy-of-cell-based-assays-in-antibody-detection/Medxy AIen2026-08-12T08:53:34-07:00Advancing Myasthenia Gravis Diagnosis: The Superior Accuracy of Cell-Based Assays in Antibody Detection https://news.medxy.ai/vi/parkinson-genetics/Medxy AIvi2026-08-12T08:52:40-07:00Bệnh học và di truyền trong một đoàn hệ toàn cầu các rối loạn Parkinson https://news.medxy.ai/pathology-and-genetics-in-a-global-cohort-of-parkinsonian-disorders/Medxy AIen2026-08-12T08:50:06-07:00Pathology and Genetics in a Global Cohort of Parkinsonian Disorders https://news.medxy.ai/zh/tc-max-anxiety-scale/Medxy AIzh2026-08-12T08:49:34-07:00甲状腺癌修订焦虑量表（TC-MAX）：评估癌症相关痛苦并指导以患者为中心照护的新工具 https://news.medxy.ai/ja/thyroid-cancer-anxiety-scale/Medxy AIja2026-08-12T08:48:56-07:00甲状腺がん修正版不安尺度（TC-MAX）：がん関連苦痛を評価し、患者中心のケアを導く新しいツール https://news.medxy.ai/vi/tc-max-anxiety-scale-2/Medxy AIvi2026-08-12T08:48:32-07:00TC-MAX: Thang đo lo âu sửa đổi dành cho ung thư tuyến giáp giúp nhận diện distress và định hướng chăm sóc lấy bệnh nhân làm trung tâm https://news.medxy.ai/the-thyroid-cancer-modified-anxiety-scale-tc-max-a-novel-tool-to-assess-cancer-related-distress-and-guide-patient-centered-care/Medxy AIen2026-08-12T08:46:32-07:00The Thyroid Cancer Modified Anxiety Scale (TC-MAX): A Novel Tool to Assess Cancer-Related Distress and Guide Patient-Centered Care https://news.medxy.ai/zh/parallel-training-fat-oxidation/Medxy AIzh2026-08-12T08:45:47-07:00并行训练可促进神经酰胺清除并增强2型糖尿病患者生活方式干预中的脂肪氧化 https://news.medxy.ai/ja/parallel-training-fatty-acid/Medxy AIja2026-08-12T08:45:15-07:00並行トレーニングはセラミドの除去を促し、2型糖尿病の脂肪酸酸化を高める https://news.medxy.ai/concurrent-training-augments-ceramide-clearance-and-enhances-fat-oxidation-in-type-2-diabetes-during-lifestyle-intervention/Medxy AIen2026-08-12T08:42:58-07:00Concurrent Training Augments Ceramide Clearance and Enhances Fat Oxidation in Type 2 Diabetes During Lifestyle Intervention https://news.medxy.ai/zh/cirrhosis-diabetes-guidelines/Medxy AIzh2026-08-12T08:42:27-07:00肝硬化合并糖尿病：实用临床管理指南 https://news.medxy.ai/ja/diabetes-liver-cirrhosis-guide/Medxy AIja2026-08-12T08:42:03-07:00肝硬変合併糖尿病をどう最適化するか：実践的臨床ガイド https://news.medxy.ai/vi/diabetes-management-cirrhosis/Medxy AIvi2026-08-12T08:41:37-07:00Tối ưu hóa quản lý đái tháo đường trong xơ gan: Hướng dẫn lâm sàng thực hành https://news.medxy.ai/optimizing-diabetes-management-in-cirrhosis-a-practical-clinical-guide/Medxy AIen2026-08-12T08:39:55-07:00Optimizing Diabetes Management in Cirrhosis: A Practical Clinical Guide https://news.medxy.ai/zh/tanzania-ai-diabetes-screening/Medxy AIzh2026-08-12T08:39:22-07:00坦桑尼亚可转诊性糖网检测：四种AI系统真实世界表现比较 https://news.medxy.ai/ja/comparative-performance-of-four-ai-systems-for-detecting-referable-diabetic-retinopathy/Medxy AIja2026-08-12T08:39:01-07:00タンザニアにおける専門医への紹介を要する糖尿病網膜症の検出を目的とした4つのAIシステムの性能比較：実臨床環境での評価 https://news.medxy.ai/vi/ai-retinopathy-detection-tanzania/Medxy AIvi2026-08-12T08:38:28-07:00So sánh hiệu năng của bốn hệ thống AI trong phát hiện bệnh võng mạc đái tháo đường có chỉ định chuyển tuyến tại Tanzania: đánh giá trong thực tế https://news.medxy.ai/comparative-performance-of-four-ai-systems-for-detecting-referable-diabetic-retinopathy-in-tanzania-a-real-world-evaluation/Medxy AIen2026-08-12T08:37:25-07:00Comparative Performance of Four AI Systems for Detecting Referable Diabetic Retinopathy in Tanzania: A Real-World Evaluation https://news.medxy.ai/zh/ai-ecg-monitoring/Medxy AIzh2026-08-12T08:37:04-07:00AI 赋能心电图能否成为肥厚型心肌病左心室功能障碍的新型监测工具？ https://news.medxy.ai/ja/hypertrophic-cardiomyopathy-ai/Medxy AIja2026-08-12T08:36:41-07:00マバカムテン治療中の肥大型心筋症における左室機能障害を捉えるAI搭載心電図の新たなサーベイランス手法 https://news.medxy.ai/vi/ai-ecg-monitoring-2/Medxy AIvi2026-08-12T08:36:17-07:00ECG hỗ trợ bởi AI: công cụ theo dõi mới cho rối loạn chức năng thất trái ở bệnh cơ tim phì đại điều trị bằng Mavacamten https://news.medxy.ai/ai-enabled-ecg-as-a-new-surveillance-tool-for-left-ventricular-dysfunction-in-hypertrophic-cardiomyopathy-on-mavacamten/Medxy AIen2026-08-12T08:34:22-07:00AI-Enabled ECG as a New Surveillance Tool for Left Ventricular Dysfunction in Hypertrophic Cardiomyopathy on Mavacamten https://news.medxy.ai/zh/unveiling-heart-failure-with-preserved-ejection-fraction-in-adults-with-congenital-heart-disease/Medxy AIzh2026-08-12T08:34:01-07:00揭示成人先天性心脏病患者射血分数保留型心力衰竭：患病率、特征及临床挑战 https://news.medxy.ai/ja/congenital-heart-failure/Medxy AIja2026-08-12T08:33:26-07:00先天性心疾患を有する成人における射出分画保持型心不全：有病率・臨床像・診療上の課題 https://news.medxy.ai/vi/hfpef-congenital-heart-disease/Medxy AIvi2026-08-12T08:32:54-07:00HFpEF ở người trưởng thành mắc bệnh tim bẩm sinh: Tỷ lệ hiện mắc, đặc điểm lâm sàng và những thách thức trong thực hành https://news.medxy.ai/unveiling-heart-failure-with-preserved-ejection-fraction-in-adults-with-congenital-heart-disease-prevalence-characteristics-and-clinical-challenges/Medxy AIen2026-08-12T08:30:49-07:00Unveiling Heart Failure with Preserved Ejection Fraction in Adults with Congenital Heart Disease: Prevalence, Characteristics, and Clinical Challenges https://news.medxy.ai/zh/sotatercept-pah-benefits/Medxy AIzh2026-08-12T08:30:21-07:00Sotatercept 在提升肺动脉高压患者运动能力中的多重作用 https://news.medxy.ai/ja/sotatercept-pah-benefits-2/Medxy AIja2026-08-12T08:27:53-07:00Sotaterceptが肺動脈性高血圧症の運動耐容能を高める多面的作用 https://news.medxy.ai/vi/sotatercept-pulmonary-hypertension/Medxy AIvi2026-08-12T08:26:59-07:00Sotatercept: Tác động đa cơ chế giúp cải thiện khả năng gắng sức trong tăng áp động mạch phổi https://news.medxy.ai/sotatercepts-multifaceted-role-in-enhancing-exercise-capacity-in-pulmonary-arterial-hypertension/Medxy AIen2026-08-12T08:24:37-07:00Sotatercept’s Multifaceted Role in Enhancing Exercise Capacity in Pulmonary Arterial Hypertension https://news.medxy.ai/harnessing-ai-enabled-ecg-for-early-detection-of-chagas-disease-a-new-frontier-in-cardiac-screening/Medxy AIen2026-08-12T08:22:31-07:00Harnessing AI-Enabled ECG for Early Detection of Chagas Disease: A New Frontier in Cardiac Screening https://news.medxy.ai/zh/nk-cell-dysfunction-mechanism/Medxy AIzh2026-08-11T22:43:29-07:00严重创伤后自然杀伤细胞功能失调的机制解析：免疫失衡与感染风险的启示 https://news.medxy.ai/ja/nk-cell-dysfunction-post-trauma/Medxy AIja2026-08-11T22:43:14-07:00重症外傷後のnatural killer細胞機能異常を読み解く：免疫調節異常と感染リスクへの示唆 https://news.medxy.ai/vi/natural-killer-cell-dysfunction/Medxy AIvi2026-08-11T22:42:55-07:00Giải mã rối loạn chức năng tế bào giết tự nhiên sau chấn thương nặng: Ý nghĩa đối với rối loạn điều hòa miễn dịch và nguy cơ nhiễm trùng https://news.medxy.ai/zh/sepsis-resuscitation-impact/Medxy AIzh2026-08-11T22:31:08-07:00院前 1 小时复苏包对脓毒性休克病死率的影响：来自 SAMU Save Sepsis 研究的启示 https://news.medxy.ai/ja/sepsis-resuscitation/Medxy AIja2026-08-11T22:30:46-07:00院前1時間蘇生バンドルは敗血症性ショックの死亡率を改善できるか：SAMU Save Sepsis試験からの知見 https://news.medxy.ai/vi/sepsis-shock-impact/Medxy AIvi2026-08-11T22:30:27-07:00Đánh giá tác động của gói hồi sức 1 giờ trước nhập viện đối với tử vong do sốc nhiễm khuẩn: Những phát hiện từ nghiên cứu SAMU Save Sepsis https://news.medxy.ai/evaluating-the-impact-of-a-prehospital-1-hour-resuscitation-bundle-on-septic-shock-mortality-insights-from-the-samu-save-sepsis-study/Medxy AIen2026-08-11T22:28:58-07:00Evaluating the Impact of a Prehospital 1-Hour Resuscitation Bundle on Septic Shock Mortality: Insights from the SAMU Save Sepsis Study https://news.medxy.ai/functional-impairment-of-natural-killer-cells-after-severe-trauma-phenotypic-shifts-and-loss-of-activating-receptors/Medxy AIen2026-08-11T22:22:43-07:00Functional Impairment of Natural Killer Cells After Severe Trauma: Phenotypic Shifts and Loss of Activating Receptors https://news.medxy.ai/zh/rocuronium-dose-intubation/Medxy AIzh2026-08-11T22:22:23-07:00罗库溴铵剂量是否影响危重患者首次插管成功率？多中心试验二次分析带来新线索 https://news.medxy.ai/ja/rocuronium-intubation-effect/Medxy AIja2026-08-11T22:22:06-07:00重症患者の初回挿管成功に対するロクロニウム投与量の影響：多施設試験の二次解析からの知見 https://news.medxy.ai/vi/rocuronium-intubation-success/Medxy AIvi2026-08-11T22:21:45-07:00Tác động của liều Rocuronium đến tỷ lệ thành công đặt ống nội khí quản ở lần thử đầu tiên ở bệnh nhân nguy kịch: góc nhìn từ phân tích thứ cấp các thử nghiệm đa trung tâm https://news.medxy.ai/impact-of-rocuronium-dose-on-first-attempt-intubation-success-in-critically-ill-patients-insights-from-a-secondary-analysis-of-multicenter-trials/Medxy AIen2026-08-11T22:20:03-07:00Impact of Rocuronium Dose on First-Attempt Intubation Success in Critically Ill Patients: Insights from a Secondary Analysis of Multicenter Trials https://news.medxy.ai/zh/approved-monoclonal-antibody-therapies-for-hidradenitis-suppurativa-efficacy-safety-and-economic/Medxy AIzh2026-08-11T10:36:48-07:00获批用于化脓性汗腺炎的单克隆抗体疗法：疗效、安全性和经济性评估 https://news.medxy.ai/ja/approved-monoclonal-antibody-therapy/Medxy AIja2026-08-11T10:36:24-07:00化膿性汗腺炎に対する承認済みモノクローナル抗体療法：有効性・安全性・経済評価 https://news.medxy.ai/vi/monoclonal-antibody-therapy/Medxy AIvi2026-08-11T10:35:55-07:00Liệu pháp kháng thể đơn dòng được phê duyệt cho hidradenitis suppurativa: Hiệu quả, độ an toàn và đánh giá kinh tế https://news.medxy.ai/approved-monoclonal-antibody-therapies-for-hidradenitis-suppurativa-efficacy-safety-and-economic-assessments/Medxy AIen2026-08-11T10:34:35-07:00Approved Monoclonal Antibody Therapies for Hidradenitis Suppurativa: Efficacy, Safety, and Economic Assessments https://news.medxy.ai/zh/pigmented-lesion-risk/Medxy AIzh2026-08-11T10:34:16-07:00周边球状结构色素性病变的动态风险分层：来自纵向队列研究的新启示 https://news.medxy.ai/ja/melanocytic-lesion-risk/Medxy AIja2026-08-11T10:33:54-07:00周辺小球を伴うメラノサイト性病変の動的リスク層別化：縦断コホート研究からの示唆 https://news.medxy.ai/vi/risk-stratification-pigmented-lesions/Medxy AIvi2026-08-11T10:33:29-07:00Phân tầng nguy cơ động trong các tổn thương hắc tố có hạt ngoại vi: Những phát hiện từ một nghiên cứu đoàn hệ theo dõi dọc https://news.medxy.ai/dynamic-risk-stratification-of-melanocytic-lesions-with-peripheral-globules-insights-from-a-longitudinal-cohort-study/Medxy AIen2026-08-11T10:32:27-07:00Dynamic Risk Stratification of Melanocytic Lesions with Peripheral Globules: Insights from a Longitudinal Cohort Study https://news.medxy.ai/zh/nasal-columella-flap/Medxy AIzh2026-08-11T10:32:08-07:00鼻小柱皮瓣：一种用于鼻小柱重建的创新性局部皮瓣技术 https://news.medxy.ai/ja/columella-flap/Medxy AIja2026-08-11T10:31:50-07:00鼻柱弁：鼻柱再建を高める革新的な局所皮弁手技 https://news.medxy.ai/vi/nasal-tip-flap/Medxy AIvi2026-08-11T10:31:29-07:00Vạt cột mũi: Kỹ thuật vạt tại chỗ mới giúp tái tạo cột mũi hiệu quả hơn https://news.medxy.ai/columella-flap-an-innovative-local-flap-technique-enhancing-nasal-columella-reconstruction/Medxy AIen2026-08-11T10:30:28-07:00Columella Flap: An Innovative Local Flap Technique Enhancing Nasal Columella Reconstruction https://news.medxy.ai/zh/six-sigma-limb-reconstruction/Medxy AIzh2026-08-11T10:30:10-07:00借助 Six Sigma 提升下肢显微外科重建效率 https://news.medxy.ai/vi/six-sigma-microsurgery/Medxy AIvi2026-08-11T10:29:30-07:00Tối ưu hóa hiệu quả tái tạo vi phẫu chi dưới nhờ sáng kiến chất lượng Six Sigma https://news.medxy.ai/enhancing-lower-extremity-microsurgical-reconstruction-efficiency-through-six-sigma-quality-initiatives/Medxy AIen2026-08-11T10:28:34-07:00Enhancing Lower Extremity Microsurgical Reconstruction Efficiency Through Six Sigma Quality Initiatives https://news.medxy.ai/optimizing-task-shared-psychosocial-interventions-for-depression-and-anxiety-key-components-and-personalized-approaches/Medxy AIen2026-08-11T10:27:20-07:00Optimizing Task-Shared Psychosocial Interventions for Depression and Anxiety: Key Components and Personalized Approaches https://news.medxy.ai/zh/drug-approval-conflicts/Medxy AIzh2026-08-11T10:26:58-07:00多项试验结果相互矛盾时的药物审批：吉哌隆缓释剂获FDA批准的曲折历程 https://news.medxy.ai/ja/gepilon-fda-approval/Medxy AIja2026-08-11T10:26:40-07:00相反する臨床試験エビデンスをどう読み解くか：大うつ病に対するゲピロン徐放錠のFDA承認までの軌跡 https://news.medxy.ai/vi/gepirone-fda-approval/Medxy AIvi2026-08-11T10:26:22-07:00Gepirone ER được FDA phê duyệt ra sao giữa những bằng chứng thử nghiệm mâu thuẫn? https://news.medxy.ai/navigating-conflicting-clinical-trial-evidence-the-fdas-approval-journey-of-gepirone-extended-release-for-major-depression/Medxy AIen2026-08-11T10:25:20-07:00Navigating Conflicting Clinical Trial Evidence: The FDA’s Approval Journey of Gepirone Extended Release for Major Depression https://news.medxy.ai/zh/pre-hospital-resuscitation-sepsis/Medxy AIzh2026-08-11T09:58:35-07:00院前1小时复苏包对脓毒性休克结局的影响：多中心研究评估 https://news.medxy.ai/ja/sepsis-shock-bundle/Medxy AIja2026-08-11T09:58:15-07:00院外1時間蘇生バンドルは敗血症性ショックの転帰を改善するか：多施設試験の検証 https://news.medxy.ai/vi/pre-hospital-resuscitation-impact/Medxy AIvi2026-08-11T09:57:39-07:00Đánh giá tác động của gói hồi sức trước viện trong 1 giờ đối với kết cục sốc nhiễm khuẩn https://news.medxy.ai/evaluating-the-impact-of-a-1-hour-prehospital-resuscitation-bundle-on-septic-shock-outcomes/Medxy AIen2026-08-11T09:56:28-07:00Evaluating the Impact of a 1-Hour Prehospital Resuscitation Bundle on Septic Shock Outcomes https://news.medxy.ai/zh/future-researchers-insights/Medxy AIzh2026-08-11T09:55:56-07:00培育未来研究者：普通内科研究进修全国调查的启示 https://news.medxy.ai/ja/general-medicine-fellowship/Medxy AIja2026-08-11T09:55:26-07:00一般内科研究者の未来を育む：全国調査から見えた研究フェローシップの実像 https://news.medxy.ai/vi/future-researchers-training/Medxy AIvi2026-08-11T09:55:04-07:00Bồi dưỡng thế hệ nhà nghiên cứu tương lai: Những phát hiện từ khảo sát toàn quốc về các chương trình nghiên cứu fellowship trong nội khoa tổng quát https://news.medxy.ai/nurturing-future-researchers-insights-from-a-national-survey-on-general-internal-medicine-research-fellowships/Medxy AIen2026-08-11T09:54:11-07:00Nurturing Future Researchers: Insights from a National Survey on General Internal Medicine Research Fellowships https://news.medxy.ai/zh/financial-incentives-hypertension/Medxy AIzh2026-08-11T09:53:37-07:00高血压管理中的财务激励：临床与健康结局如何变化？一项全面综述 https://news.medxy.ai/ja/hypertension-incentives-review/Medxy AIja2026-08-11T09:52:56-07:00高血圧管理における金銭的インセンティブの臨床的・健康アウトカムを検証する：包括的レビュー https://news.medxy.ai/vi/evaluating-the-clinical-and-health-outcomes-of-financial-incentives-in-hypertension-management/Medxy AIvi2026-08-11T09:52:21-07:00Đánh giá kết quả lâm sàng và sức khỏe của các biện pháp khuyến khích tài chính trong quản lý tăng huyết áp: Một bài tổng quan toàn diện https://news.medxy.ai/evaluating-the-clinical-and-health-outcomes-of-financial-incentives-in-hypertension-management-a-comprehensive-review/Medxy AIen2026-08-11T09:50:43-07:00Evaluating the Clinical and Health Outcomes of Financial Incentives in Hypertension Management: A Comprehensive Review https://news.medxy.ai/zh/afib-mitral-stenosis-risk/Medxy AIzh2026-08-11T09:50:25-07:00房颤合并二尖瓣狭窄：DOACs与华法林在卒中和心脏风险中的权衡 https://news.medxy.ai/ja/stroke-heart-events-doacs-vs-warfarin/Medxy AIja2026-08-11T09:50:07-07:00脳卒中と心臓イベントのはざまで：僧帽弁狭窄症を伴う心房細動におけるDOACsとワルファリンの比較 https://news.medxy.ai/vi/stroke-heart-risk-doacs-warfarin/Medxy AIvi2026-08-11T09:49:47-07:00Cân bằng nguy cơ đột quỵ và tim mạch: DOACs so với warfarin trong rung nhĩ kèm hẹp van hai lá https://news.medxy.ai/balancing-stroke-and-cardiac-risks-doacs-versus-warfarin-in-atrial-fibrillation-with-mitral-stenosis/Medxy AIen2026-08-11T09:48:44-07:00Balancing Stroke and Cardiac Risks: DOACs versus Warfarin in Atrial Fibrillation with Mitral Stenosis https://news.medxy.ai/zh/early-inflammation-hsct/Medxy AIzh2026-08-11T09:48:14-07:00儿童单倍型相合HSCT联合移植后环磷酰胺后早期炎症并发症：临床影响与危险因素 https://news.medxy.ai/ja/early-inflammatory-complications/Medxy AIja2026-08-11T09:47:31-07:00小児半合致HSCTにおける移植後シクロホスファミド後の早期炎症性合併症：臨床的影響と危険因子 https://news.medxy.ai/vi/early-hsct-complications/Medxy AIvi2026-08-11T09:46:56-07:00Biến chứng viêm sớm sau ghép haplo-HSCT ở trẻ em với cyclophosphamide sau ghép: tác động lâm sàng và các yếu tố nguy cơ https://news.medxy.ai/early-inflammatory-complications-after-pediatric-haploidentical-hsct-with-post-transplant-cyclophosphamide-clinical-impact-and-risk-factors/Medxy AIen2026-08-11T09:45:36-07:00Early Inflammatory Complications After Pediatric Haploidentical HSCT with Post-Transplant Cyclophosphamide: Clinical Impact and Risk Factors https://news.medxy.ai/zh/tumor-immune-microenvironment/Medxy AIzh2026-08-11T09:45:03-07:00解码弥漫大B细胞淋巴瘤的肿瘤免疫微环境：基于CD163与CD11c分型的预后启示 https://news.medxy.ai/ja/diffuse-large-b-cell-lymphoma/Medxy AIja2026-08-11T09:44:44-07:00びまん性大細胞型B細胞リンパ腫の腫瘍免疫微小環境を読み解く：CD163・CD11cプロファイリングからみた予後予測 https://news.medxy.ai/vi/immune-microenvironment-lymphoma/Medxy AIvi2026-08-11T09:44:03-07:00Giải mã vi môi trường miễn dịch của u lympho tế bào B lớn lan tỏa: Những gợi ý tiên lượng từ phân tích CD163 và CD11c https://news.medxy.ai/decoding-the-tumor-immune-microenvironment-in-diffuse-large-b-cell-lymphoma-prognostic-insights-from-cd163-and-cd11c-profiling/Medxy AIen2026-08-11T09:42:36-07:00Decoding the Tumor Immune Microenvironment in Diffuse Large B-Cell Lymphoma: Prognostic Insights from CD163 and CD11c Profiling https://news.medxy.ai/zh/folate-bone-marrow/Medxy AIzh2026-08-11T09:42:18-07:00揭示 FOLR2-IRF2BP2 轴：过量叶酸如何损害骨髓增生异常性肿瘤中的红细胞生成 https://news.medxy.ai/ja/folr2-irf2bp2-axis/Medxy AIja2026-08-11T09:41:58-07:00FOLR2-IRF2BP2軸の解明：過剰葉酸はいかにして骨髄異形成腫瘍の赤血球造血を障害するのか https://news.medxy.ai/vi/folate-overload-anemia/Medxy AIvi2026-08-11T09:41:23-07:00Làm sáng tỏ trục FOLR2-IRF2BP2: Vì sao dư thừa axit folic làm suy giảm sinh hồng cầu trong tân sinh loạn sản tủy https://news.medxy.ai/unraveling-the-folr2-irf2bp2-axis-how-excess-folic-acid-impairs-erythropoiesis-in-myelodysplastic-neoplasms/Medxy AIen2026-08-11T09:40:11-07:00Unraveling the FOLR2-IRF2BP2 Axis: How Excess Folic Acid Impairs Erythropoiesis in Myelodysplastic Neoplasms https://news.medxy.ai/zh/abelacimab-bleeding-risk/Medxy AIzh2026-08-11T09:39:54-07:00心房颤动中的 Abelacimab：既往抗凝经验如何影响出血风险 https://news.medxy.ai/ja/abelacimab-bleeding-risk-2/Medxy AIja2026-08-11T09:39:39-07:00心房細動におけるabelacimab：抗凝固歴が出血リスクに及ぼす影響 https://news.medxy.ai/vi/abelacimab-atrial-fibrillation/Medxy AIvi2026-08-11T09:39:21-07:00Abelacimab trong rung nhĩ: ảnh hưởng của kinh nghiệm chống đông trước đó lên nguy cơ chảy máu https://news.medxy.ai/abelacimab-in-atrial-fibrillation-impact-of-prior-anticoagulation-experience-on-bleeding-risk/Medxy AIen2026-08-11T09:38:14-07:00Abelacimab in Atrial Fibrillation: Impact of Prior Anticoagulation Experience on Bleeding Risk https://news.medxy.ai/zh/chronic-cough-brain-changes/Medxy AIzh2026-08-11T09:37:50-07:00慢性咳嗽与脑结构改变：一项大规模纵向研究的新启示 https://news.medxy.ai/ja/chronic-cough-brain-changes-2/Medxy AIja2026-08-11T09:37:30-07:00慢性咳嗽に伴う脳構造変化：大規模縦断研究から見えた新知見 https://news.medxy.ai/vi/brain-structure-changes/Medxy AIvi2026-08-11T09:36:56-07:00Biến đổi cấu trúc não trong ho mạn tính: Góc nhìn từ một nghiên cứu theo dõi dọc quy mô lớn https://news.medxy.ai/brain-structure-changes-in-chronic-cough-insights-from-a-large-scale-longitudinal-study/Medxy AIen2026-08-11T09:35:30-07:00Brain Structure Changes in Chronic Cough: Insights from a Large-Scale Longitudinal Study https://news.medxy.ai/zh/high-dose-rocuronium/Medxy AIzh2026-08-11T09:22:58-07:00高剂量罗库溴铵可提高危重ICU患者首次插管成功率：来自多中心试验二次分析的启示 https://news.medxy.ai/ja/high-dose-rocuronium-2/Medxy AIja2026-08-11T09:22:24-07:00高用量ロクロニウムは重症ICU患者の初回気管挿管成功率を向上させる：多施設試験の二次解析から得られた知見 https://news.medxy.ai/vi/high-dose-rocuronium-success/Medxy AIvi2026-08-11T09:22:00-07:00Rocuronium liều cao giúp tăng tỷ lệ đặt nội khí quản thành công ngay lần đầu ở bệnh nhân nặng tại ICU: Góc nhìn từ phân tích thứ cấp của các thử nghiệm đa trung tâm https://news.medxy.ai/high-dose-rocuronium-enhances-first-attempt-intubation-success-in-critically-ill-icu-patients-insights-from-secondary-analysis-of-multicenter-trials/Medxy AIen2026-08-11T09:20:31-07:00High-Dose Rocuronium Enhances First-Attempt Intubation Success in Critically Ill ICU Patients: Insights from Secondary Analysis of Multicenter Trials https://news.medxy.ai/zh/prism-glaucoma-risk/Medxy AIzh2026-08-11T09:20:11-07:00PRISM 分期体系：开角型青光眼的全面分级与风险分层新框架 https://news.medxy.ai/ja/prism-framework-glaucoma/Medxy AIja2026-08-11T09:19:36-07:00PRISMフレームワーク：開放隅角緑内障のための包括的病期分類システムとリスク層別化 https://news.medxy.ai/vi/prism-glaucoma-staging/Medxy AIvi2026-08-11T09:19:12-07:00Khung PRISM: Hệ thống phân giai đoạn toàn diện cho glôcôm góc mở và phân tầng nguy cơ https://news.medxy.ai/prism-framework-a-comprehensive-staging-system-for-open-angle-glaucoma-and-risk-stratification/Medxy AIen2026-08-11T09:17:43-07:00PRISM Framework: A Comprehensive Staging System for Open-Angle Glaucoma and Risk Stratification https://news.medxy.ai/zh/predicting-progression-in-intermediate-amd-the-role-of-ellipsoid-zone-integrity-and-quantitative-oct-biomarkers/Medxy AIzh2026-08-11T09:17:11-07:00预测中度年龄相关性黄斑变性（AMD）的进展：椭圆体区完整性与定量OCT生物标志物的关键作用 https://news.medxy.ai/ja/amd-progression-markers/Medxy AIja2026-08-11T09:16:50-07:00中間期AMDの進行をどう見抜くか：楕円体帯の保全性と定量OCTバイオマーカーが鍵を握る https://news.medxy.ai/vi/amd-progression-forecast/Medxy AIvi2026-08-11T09:16:08-07:00Dự báo tiến triển AMD trung gian: Vai trò then chốt của tính toàn vẹn vùng ellipsoid zone và các biomarker OCT định lượng https://news.medxy.ai/predicting-progression-in-intermediate-amd-the-crucial-role-of-ellipsoid-zone-integrity-and-quantitative-oct-biomarkers/Medxy AIen2026-08-11T09:14:17-07:00Predicting Progression in Intermediate AMD: The Crucial Role of Ellipsoid Zone Integrity and Quantitative OCT Biomarkers https://news.medxy.ai/zh/pembrolizumab-head-neck-cancer-2/Medxy AIzh2026-08-11T09:13:56-07:00围手术期帕博利珠单抗用于头颈癌的成本效果：PD-L1表达水平的影响 https://news.medxy.ai/ja/cost-effectiveness-pembrolizumab/Medxy AIja2026-08-11T09:13:29-07:00頭頸部癌における周術期ペムブロリズマブの費用対効果：PD-L1発現レベルの影響 https://news.medxy.ai/vi/pembrolizumab-surgery-cost-effectiveness/Medxy AIvi2026-08-11T09:13:06-07:00Pembrolizumab quanh phẫu thuật trong ung thư đầu và cổ: hiệu quả chi phí phụ thuộc mức biểu hiện PD-L1 https://news.medxy.ai/cost-effectiveness-of-perioperative-pembrolizumab-in-head-and-neck-cancer-impact-of-pd-l1-expression-levels/Medxy AIen2026-08-11T09:11:15-07:00Cost-Effectiveness of Perioperative Pembrolizumab in Head and Neck Cancer: Impact of PD-L1 Expression Levels https://news.medxy.ai/zh/botox-treatment-monitoring/Medxy AIzh2026-08-11T09:10:40-07:00用自动化声学指标评估内收型喉肌张力障碍的肉毒毒素治疗监测 https://news.medxy.ai/ja/automated-acoustic-metrics-for-monitoring-botulinum-toxin-treatment-in-adductor-laryngeal-dystonia/Medxy AIja2026-08-11T09:10:02-07:00内転型喉頭ジストニアにおけるボツリヌス毒素治療のモニタリングを目的とした自動音響指標の評価 https://news.medxy.ai/vi/botulinum-treatment-monitoring/Medxy AIvi2026-08-11T09:09:34-07:00Đánh giá các chỉ số âm học tự động trong theo dõi điều trị độc tố botulinum ở loạn trương lực thanh quản khép https://news.medxy.ai/evaluating-automated-acoustic-metrics-for-monitoring-botulinum-toxin-treatment-in-adductor-laryngeal-dystonia/Medxy AIen2026-08-11T09:08:14-07:00Evaluating Automated Acoustic Metrics for Monitoring Botulinum Toxin Treatment in Adductor Laryngeal Dystonia https://news.medxy.ai/zh/hernia-surgery-outcomes/Medxy AIzh2026-08-11T09:07:52-07:00手术量会影响腹股沟疝修补结局吗？——瑞典全国队列研究提示的启示 https://news.medxy.ai/ja/hernia-repair-outcomes/Medxy AIja2026-08-11T09:06:59-07:00開放メッシュ鼠径ヘルニア修復後の再発と合併症に対する手術件数の影響：スウェーデン全国コホートからの知見 https://news.medxy.ai/vi/hernia-surgery-volume/Medxy AIvi2026-08-11T09:05:39-07:00Khối lượng phẫu thuật của đơn vị ảnh hưởng ra sao đến tái phát và biến chứng sau sửa chữa thoát vị bẹn trước hở có lưới? Dữ liệu từ một đoàn hệ toàn quốc của Thụy Điển https://news.medxy.ai/impact-of-surgical-unit-volume-on-recurrence-and-complications-after-open-mesh-groin-hernia-repair-insights-from-a-nationwide-swedish-cohort/Medxy AIen2026-08-11T09:04:17-07:00Impact of Surgical Unit Volume on Recurrence and Complications after Open Mesh Groin Hernia Repair: Insights from a Nationwide Swedish Cohort https://news.medxy.ai/vi/natural-killer-cell-kinetics/Medxy AIvi2026-08-11T08:59:32-07:00Biến đổi động học kiểu hình tế bào diệt tự nhiên và biểu hiện thụ thể hoạt hóa sau chấn thương: Góc nhìn về rối loạn điều hòa miễn dịch https://news.medxy.ai/dynamic-alterations-in-natural-killer-cell-phenotype-and-activating-receptor-expression-following-trauma-insights-into-immune-dysregulation/Medxy AIen2026-08-11T08:58:09-07:00Dynamic Alterations in Natural Killer Cell Phenotype and Activating Receptor Expression Following Trauma: Insights into Immune Dysregulation https://news.medxy.ai/zh/androgen-receptor-therapy/Medxy AIzh2026-08-11T08:57:34-07:00复发性成人型卵巢颗粒细胞瘤中雄激素受体抑制联合激素治疗的疗效评估：来自Ⅱ期研究的启示 https://news.medxy.ai/vi/androgen-receptor-inhibition/Medxy AIvi2026-08-11T08:56:40-07:00Đánh giá ức chế thụ thể androgen phối hợp điều trị nội tiết trong u tế bào hạt buồng trứng тип người trưởng thành tái phát: Góc nhìn từ nghiên cứu giai đoạn II https://news.medxy.ai/evaluating-androgen-receptor-inhibition-combined-with-hormonal-therapies-in-recurrent-adult-type-ovarian-granulosa-cell-tumor-insights-from-a-phase-ii-study/Medxy AIen2026-08-11T08:55:00-07:00Evaluating Androgen Receptor Inhibition Combined with Hormonal Therapies in Recurrent Adult-Type Ovarian Granulosa Cell Tumor: Insights from a Phase II Study https://news.medxy.ai/zh/cervical-hardness-assessment/Medxy AIzh2026-08-11T08:54:25-07:00引产前宫颈硬度评估：基于 Pregnolia System 的可行性与初步观察 https://news.medxy.ai/ja/cervical-ripening-evaluation/Medxy AIja2026-08-11T08:53:58-07:00分娩誘発前の子宮頸部硬度評価：Pregnolia System による実現可能性と初期知見 https://news.medxy.ai/vi/cervical-ripeness-assessment/Medxy AIvi2026-08-11T08:53:29-07:00Đánh giá độ cứng cổ tử cung trước khởi phát chuyển dạ: Tính khả thi và những nhận định ban đầu từ Hệ thống Pregnolia https://news.medxy.ai/evaluating-cervical-stiffness-before-labour-induction-feasibility-and-preliminary-insights-using-the-pregnolia-system/Medxy AIen2026-08-11T08:52:04-07:00Evaluating Cervical Stiffness Before Labour Induction: Feasibility and Preliminary Insights Using the Pregnolia System https://news.medxy.ai/ja/magnesium-preterm-birth/Medxy AIja2026-08-11T08:51:05-07:00極早産前の出生前硫酸マグネシウム：脳性麻痺を伴わない生存改善との実臨床関連 https://news.medxy.ai/vi/magnesium-sulfate-preterm/Medxy AIvi2026-08-11T08:50:19-07:00Magnesium sulfate trước sinh trước sinh rất non: liên hệ thực tế với cải thiện khả năng sống sót không bại não https://news.medxy.ai/antenatal-magnesium-sulfate-prior-to-very-preterm-birth-real-world-association-with-improved-survival-without-cerebral-palsy/Medxy AIen2026-08-11T08:48:06-07:00Antenatal Magnesium Sulfate Prior to Very Preterm Birth: Real-World Association with Improved Survival Without Cerebral Palsy https://news.medxy.ai/zh/opioid-use-hysterectomy/Medxy AIzh2026-08-11T08:47:32-07:00阿片类药物使用障碍与子宫切除术结局的关联：一项全面的临床综述 https://news.medxy.ai/association-between-opioid-use-disorder-and-hysterectomy-outcomes-a-comprehensive-clinical-review/Medxy AIen2026-08-11T08:44:34-07:00Association Between Opioid Use Disorder and Hysterectomy Outcomes: A Comprehensive Clinical Review https://news.medxy.ai/zh/statins-primary-biliary-cirrhosis/Medxy AIzh2026-08-11T08:44:08-07:00他汀使用与原发性胆汁性胆管炎肝功能失代偿风险降低：来自目标试验模拟研究的启示 https://news.medxy.ai/vi/statins-liver-failure-risk/Medxy AIvi2026-08-11T08:43:02-07:00Statin giúp giảm nguy cơ mất bù gan trong viêm đường mật nguyên phát do tự miễn: Góc nhìn từ nghiên cứu mô phỏng thử nghiệm đích https://news.medxy.ai/statin-use-and-reduced-hepatic-decompensation-risk-in-primary-biliary-cholangitis-insights-from-a-target-trial-emulation-study/Medxy AIen2026-08-11T08:40:34-07:00Statin Use and Reduced Hepatic Decompensation Risk in Primary Biliary Cholangitis: Insights from a Target Trial Emulation Study https://news.medxy.ai/zh/lynch-syndrome-surveillance/Medxy AIzh2026-08-11T08:40:12-07:00Lynch综合征中的结肠镜监测：英国NHS全国队列中对结直肠癌结局的影响 https://news.medxy.ai/ja/lynch-syndrome-colonoscopy/Medxy AIja2026-08-11T08:39:31-07:00Lynch症候群における大腸内視鏡サーベイランス：英国NHS全国コホートでみた結腸直腸癌転帰への影響 https://news.medxy.ai/vi/lynch-syndrome-colonoscopy-2/Medxy AIvi2026-08-11T08:38:58-07:00Theo dõi nội soi đại tràng trong hội chứng Lynch: Tác động đến kết cục ung thư đại trực tràng trong một đoàn hệ NHS toàn quốc https://news.medxy.ai/surveillance-colonoscopy-in-lynch-syndrome-impact-on-colorectal-cancer-outcomes-in-a-national-nhs-cohort/Medxy AIen2026-08-11T08:36:59-07:00Surveillance Colonoscopy in Lynch Syndrome: Impact on Colorectal Cancer Outcomes in a National NHS Cohort https://news.medxy.ai/zh/large-vessel-occlusion-stroke/Medxy AIzh2026-08-11T08:36:34-07:00晚到院大血管闭塞卒中再灌注治疗新策略：常压高氧联合血管内取栓的临床研究 https://news.medxy.ai/ja/stroke-recovery-adjunctive-normobaric-hyperoxia-with-endovascular-thrombectomy-in-late-presenting-large-vessel-occlusion/Medxy AIja2026-08-11T08:35:57-07:00脳卒中後の回復促進：発症後時間が経過した大血管閉塞に対する血管内血栓回収術と常圧高濃度酸素療法の併用 https://news.medxy.ai/vi/enhancing-stroke-recovery-adjunctive-normobaric-hyperoxia-with-endovascular-thrombectomy/Medxy AIvi2026-08-11T08:35:19-07:00Tăng cường khả năng hồi phục sau đột quỵ: Liệu pháp bổ trợ thở oxy áp suất thường nồng độ cao kết hợp lấy huyết khối qua đường nội mạch ở bệnh nhân tắc mạch máu lớn nhập viện muộn. https://news.medxy.ai/enhancing-stroke-recovery-adjunctive-normobaric-hyperoxia-with-endovascular-thrombectomy-in-late-presenting-large-vessel-occlusion/Medxy AIen2026-08-11T08:33:55-07:00Enhancing Stroke Recovery: Adjunctive Normobaric Hyperoxia with Endovascular Thrombectomy in Late-Presenting Large Vessel Occlusion https://news.medxy.ai/zh/brain-age-dementia-risk/Medxy AIzh2026-08-11T08:33:17-07:00脑年龄差异助力主观认知下降患者痴呆风险分层，优于常规MRI评估 https://news.medxy.ai/ja/brain-predicted-age-difference-enhances-dementia-risk-stratification-in-subjective-cognitive-decline-beyond-mri-assessment/Medxy AIja2026-08-11T08:32:56-07:00脳年齢予測に基づく年齢差は、標準的なMRI評価を超えて、主観的認知機能低下（SCD）における認知症リスクの層別化を向上させる https://news.medxy.ai/vi/brain-age-gap/Medxy AIvi2026-08-11T08:32:21-07:00Chênh lệch tuổi não dự đoán: Tăng khả năng phân tầng nguy cơ sa sút trí tuệ ở suy giảm nhận thức chủ quan vượt trên MRI chuẩn https://news.medxy.ai/brain-predicted-age-difference-enhances-dementia-risk-stratification-in-subjective-cognitive-decline-beyond-standard-mri-assessment/Medxy AIen2026-08-11T08:30:34-07:00Brain-Predicted Age Difference Enhances Dementia Risk Stratification in Subjective Cognitive Decline Beyond Standard MRI Assessment https://news.medxy.ai/zh/acute-stroke-bp-targets/Medxy AIzh2026-08-11T08:30:15-07:00急性缺血性卒中血管内治疗后血压目标如何个体化：一项临床试验带来的启示 https://news.medxy.ai/ja/blood-pressure-management-2/Medxy AIja2026-08-11T08:29:57-07:00急性虚血性脳卒中における血管内治療後の血圧目標をどう調整するか：臨床試験からの示唆 https://news.medxy.ai/vi/personalized-blood-pressure-goals-3/Medxy AIvi2026-08-11T08:29:36-07:00Cá thể hóa mục tiêu huyết áp sau điều trị nội mạch ở đột quỵ thiếu máu cục bộ cấp: những phát hiện từ thử nghiệm lâm sàng https://news.medxy.ai/tailoring-blood-pressure-targets-after-endovascular-therapy-in-acute-ischemic-stroke-clinical-trial-insights/Medxy AIen2026-08-11T08:27:26-07:00Tailoring Blood Pressure Targets After Endovascular Therapy in Acute Ischemic Stroke: Clinical Trial Insights https://news.medxy.ai/zh/liver-thyroid-hormones/Medxy AIzh2026-08-11T08:25:10-07:00终末期 MASH 中肝脏、门静脉与全身甲状腺激素改变：T3/rT3 比值与 T4 的不同诊断和预后意义 https://news.medxy.ai/ja/liver-portal-and-systemic-thyroid-hormone-alterations-in-end-stage-mash-diagnostic-and-prognostic-roles-for-t3-rt3-ratio-and-t4/Medxy AIja2026-08-11T08:23:33-07:00末期MASHにおける肝臓・門脈・全身の甲状腺ホルモン変動：T3/rT3比およびT4が担う独自の診断的・予後予測的役割 https://news.medxy.ai/vi/thyroid-hormone-disorders-mash/Medxy AIvi2026-08-11T08:23:05-07:00Rối loạn hormone tuyến giáp ở gan, tĩnh mạch cửa và toàn thân trong MASH giai đoạn cuối: Vai trò chẩn đoán và tiên lượng khác biệt của tỷ lệ T3/rT3 và T4 https://news.medxy.ai/liver-portal-and-systemic-thyroid-hormone-alterations-in-end-stage-mash-distinct-diagnostic-and-prognostic-roles-for-t3-rt3-ratio-and-t4/Medxy AIen2026-08-11T08:20:06-07:00Liver, Portal, and Systemic Thyroid Hormone Alterations in End-Stage MASH: Distinct Diagnostic and Prognostic Roles for T3/rT3 Ratio and T4 https://news.medxy.ai/zh/type-1-diabetes-faecal-elastase-low/Medxy AIzh2026-08-11T08:19:02-07:001型糖尿病中粪便弹性蛋白酶偏低：病程延长相关的外分泌性胰腺功能不全提示 https://news.medxy.ai/ja/type-1-diabetes-elastase/Medxy AIja2026-08-11T08:18:35-07:001型糖尿病における便中エラスターゼ低値：罹病期間と関連する外分泌膵機能不全の臨床的意義 https://news.medxy.ai/vi/elastase-diabetes-type-1/Medxy AIvi2026-08-11T08:16:29-07:00Elastase trong phân thấp ở đái tháo đường type 1: Ý nghĩa của suy tụy ngoại tiết liên quan đến thời gian mắc bệnh https://news.medxy.ai/low-faecal-elastase-in-type-1-diabetes-implications-of-exocrine-pancreatic-insufficiency-linked-to-disease-duration/Medxy AIen2026-08-11T08:14:37-07:00Low Faecal Elastase in Type 1 Diabetes: Implications of Exocrine Pancreatic Insufficiency Linked to Disease Duration https://news.medxy.ai/zh/temple-syndrome/Medxy AIzh2026-08-11T08:13:51-07:00Temple综合征：揭示隐匿的多系统生长障碍，并提出新的诊断评分 https://news.medxy.ai/ja/temple-syndrome-3/Medxy AIja2026-08-11T08:13:29-07:00Temple syndromeの実像：見逃されてきた多系統成長障害と新規診断スコアの提案 https://news.medxy.ai/vi/temple-syndrome-2/Medxy AIvi2026-08-11T08:12:51-07:00Hội chứng Temple: Giải mã một rối loạn tăng trưởng đa hệ thống tiềm ẩn và đề xuất thang điểm chẩn đoán mới https://news.medxy.ai/temple-syndrome-unveiling-a-hidden-multi-system-growth-disorder-and-introducing-a-new-diagnostic-score/Medxy AIen2026-08-11T08:10:35-07:00Temple Syndrome: Unveiling a Hidden Multi-System Growth Disorder and Introducing a New Diagnostic Score https://news.medxy.ai/zh/c-peptide-type-1-diabetes/Medxy AIzh2026-08-11T08:10:17-07:00残余C肽对1型糖尿病长期结局的影响：来自苏格兰队列的研究启示 https://news.medxy.ai/ja/c-peptide-impact/Medxy AIja2026-08-11T08:09:46-07:001型糖尿病の長期転帰に対する残存Cペプチドの影響：スコットランドコホートからの知見 https://news.medxy.ai/vi/c-peptide-prognosis-diabetes/Medxy AIvi2026-08-11T08:09:08-07:00C-peptide còn lại ảnh hưởng thế nào đến tiên lượng dài hạn ở đái tháo đường typ 1? Dữ liệu từ đoàn hệ Scotland https://news.medxy.ai/impact-of-residual-c-peptide-on-long-term-outcomes-in-type-1-diabetes-insights-from-the-scottish-cohort/Medxy AIen2026-08-11T08:07:08-07:00Impact of Residual C-Peptide on Long-Term Outcomes in Type 1 Diabetes: Insights from the Scottish Cohort https://news.medxy.ai/zh/62168-2/Medxy AIzh2026-08-11T08:06:31-07:00每周一次 2.4 mg 司美格鲁肽治疗中国超重或肥胖成人的疗效与安全性：基于 STEP 12 试验及区域性证据的分析 https://news.medxy.ai/ja/62167-2/Medxy AIja2026-08-11T08:06:08-07:00過体重または肥満の中国人成人における週1回投与セマグルチド2.4 mgの有効性および安全性：STEP 12試験および地域のエビデンスからの知見 https://news.medxy.ai/vi/semaglutide-safety-efficiency/Medxy AIvi2026-08-11T08:05:41-07:00Hiệu quả và độ an toàn của semaglutide 2,4 mg dùng 1 lần/tuần ở người Trung Quốc thừa cân hoặc béo phì: Góc nhìn từ thử nghiệm STEP 12 và bằng chứng khu vực https://news.medxy.ai/efficacy-and-safety-of-once-weekly-semaglutide-2-4-mg-in-chinese-adults-with-overweight-or-obesity-insights-from-the-step-12-trial-and-regional-evidence/Medxy AIen2026-08-11T08:02:18-07:00Efficacy and Safety of Once-Weekly Semaglutide 2.4 mg in Chinese Adults with Overweight or Obesity: Insights from the STEP 12 Trial and Regional Evidence https://news.medxy.ai/zh/endogenous-insulin-resistance/Medxy AIzh2026-08-11T08:01:35-07:00内源性胰岛素升高与胰岛素抵抗：进展性舒张功能障碍及心血管风险的临床证据综述 https://news.medxy.ai/ja/insulin-resistance-cardiovascular-risk/Medxy AIja2026-08-11T07:59:55-07:00内因性インスリン高値とインスリン抵抗性が示す、拡張機能障害進行と心血管リスクの新たな関連 https://news.medxy.ai/vi/high-insulin-resistance/Medxy AIvi2026-08-11T07:59:27-07:00Insulin nội sinh tăng cao và kháng insulin: dấu ấn chuyển hóa sớm liên quan tiến triển rối loạn chức năng tâm trương và nguy cơ tim mạch https://news.medxy.ai/elevated-endogenous-insulin-and-insulin-resistance-in-progressive-diastolic-dysfunction-and-cardiovascular-risk-a-comprehensive-clinical-review/Medxy AIen2026-08-11T07:56:52-07:00Elevated Endogenous Insulin and Insulin Resistance in Progressive Diastolic Dysfunction and Cardiovascular Risk: A Comprehensive Clinical Review https://news.medxy.ai/zh/adult-subaortic-stenosis/Medxy AIzh2026-08-11T07:56:17-07:00成人主动脉瓣下狭窄：临床病程与长期结局 https://news.medxy.ai/ja/adult-subaortic-stenosis-2/Medxy AIja2026-08-11T07:55:47-07:00成人の大動脈弁下狭窄：臨床経過と長期転帰 https://news.medxy.ai/vi/aortic-coarctation-adults/Medxy AIvi2026-08-11T07:55:01-07:00Hẹp động mạch chủ dưới van ở người lớn: diễn tiến lâm sàng và kết cục dài hạn https://news.medxy.ai/subvalvular-aortic-stenosis-in-adults-clinical-course-and-long-term-outcomes/Medxy AIen2026-08-11T07:52:36-07:00Subvalvular Aortic Stenosis in Adults: Clinical Course and Long-Term Outcomes https://news.medxy.ai/zh/oral-pcsk9-inhibitor-benefits/Medxy AIzh2026-08-11T07:52:17-07:00口服PCSK9抑制剂依立西地显著优于现有口服非他汀方案降脂 https://news.medxy.ai/ja/enrichid-ldl-c-reduction/Medxy AIja2026-08-11T07:51:54-07:00エンリシチド：経口PCSK9阻害薬によるLDL-C低下の新展開、既存の経口非スタチン療法を上回る可能性 https://news.medxy.ai/vi/enlicitide-pcsk9-inhibitor/Medxy AIvi2026-08-11T07:51:29-07:00Enlicitide: Chất ức chế PCSK9 đường uống đột phá giúp giảm LDL-C vượt trội so với các liệu pháp không phải statin đường uống hiện có https://news.medxy.ai/enlicitide-a-breakthrough-oral-pcsk9-inhibitor-offering-superior-ldl-c-reduction-compared-to-established-oral-nonstatin-therapies/Medxy AIen2026-08-11T07:49:22-07:00Enlicitide: A Breakthrough Oral PCSK9 Inhibitor Offering Superior LDL-C Reduction Compared to Established Oral Nonstatin Therapies https://news.medxy.ai/zh/silent-killer/Medxy AIzh2026-08-10T23:14:21-07:00心脏性猝死背后的“沉默杀手”：揭示隐匿性心脏病变 https://news.medxy.ai/ja/silent-heart-lesions/Medxy AIja2026-08-10T23:14:01-07:00心臓突然死の背後に潜む“静かな病変”を暴く：見逃されていた心病変の実態 https://news.medxy.ai/vi/silent-killers-heart-diseases/Medxy AIvi2026-08-10T23:13:40-07:00Những “kẻ giết người thầm lặng”: Hé lộ các bệnh lý tim ẩn đứng sau tử vong tim đột ngột https://news.medxy.ai/silent-killers-unveiling-the-hidden-cardiac-pathologies-behind-sudden-cardiac-death/Medxy AIen2026-08-10T23:12:04-07:00Silent Killers: Unveiling the Hidden Cardiac Pathologies Behind Sudden Cardiac Death https://news.medxy.ai/zh/transgender-breast-augmentation/Medxy AIzh2026-08-10T18:59:21-07:00跨性别女性乳房增大术：乳晕周与乳房下皱襞入路的结局比较——一项前瞻性研究 https://news.medxy.ai/ja/transgender-breast-augmentation-2/Medxy AIja2026-08-10T18:59:05-07:00トランスジェンダー女性の豊胸術：乳輪周囲切開と乳房下縁切開の転帰比較による前向き研究 https://news.medxy.ai/vi/breast-implant-comparison/Medxy AIvi2026-08-10T18:58:46-07:00Kết quả so sánh giữa đặt túi ngực qua đường quanh quầng vú và đường nếp dưới vú ở phụ nữ chuyển giới: một nghiên cứu tiền cứu https://news.medxy.ai/comparative-outcomes-of-periareolar-versus-inframammary-breast-augmentation-in-transgender-women-a-prospective-study/Medxy AIen2026-08-10T18:57:54-07:00Comparative Outcomes of Periareolar versus Inframammary Breast Augmentation in Transgender Women: A Prospective Study https://news.medxy.ai/zh/glp-1-substance-disorder/Medxy AIzh2026-08-10T18:56:25-07:00GLP-1受体激动剂或可降低酒精与物质使用障碍住院风险：来自瑞典全国性研究的启示 https://news.medxy.ai/ja/glp-1-receptor-agonists-reduce-hospital-admissions-for-alcohol-and-substance-use-disorders/Medxy AIja2026-08-10T18:56:04-07:00GLP-1受容体作動薬はアルコールおよび薬物使用障害による入院を減少させる可能性がある：スウェーデンの全国規模の調査からの知見 https://news.medxy.ai/vi/glp-1-receptor-agonists-may-reduce-hospital-admissions-for-alcohol-and-substance-use-disorders/Medxy AIvi2026-08-10T18:55:43-07:00Thuốc chủ vận thụ thể GLP-1 có thể làm giảm tỷ lệ nhập viện do rối loạn sử dụng rượu và các chất gây nghiện: Kết quả từ một nghiên cứu quy mô toàn quốc tại Thụy Điển https://news.medxy.ai/glp-1-receptor-agonists-may-reduce-hospital-admissions-for-alcohol-and-substance-use-disorders-insights-from-a-swedish-nationwide-study/Medxy AIen2026-08-10T18:54:38-07:00GLP-1 Receptor Agonists May Reduce Hospital Admissions for Alcohol and Substance Use Disorders: Insights from a Swedish Nationwide Study https://news.medxy.ai/ja/accelerated-ttms-depression/Medxy AIja2026-08-10T18:35:47-07:00うつ病に対する加速型経頭蓋磁気刺激：機能的結合ベース標的と頭皮ベース標的の比較無作為化臨床試験 https://news.medxy.ai/vi/atms-depression-location/Medxy AIvi2026-08-10T18:35:29-07:00Định vị aTMS cho trầm cảm: dựa trên kết nối chức năng hay mốc da đầu? Một thử nghiệm lâm sàng ngẫu nhiên https://news.medxy.ai/connectivity-vs-scalp-based-targeting-of-accelerated-transcranial-magnetic-stimulation-for-depression-a-randomized-clinical-trial/Medxy AIen2026-08-10T18:34:41-07:00Connectivity- vs Scalp-Based Targeting of Accelerated Transcranial Magnetic Stimulation for Depression: A Randomized Clinical Trial https://news.medxy.ai/zh/medicare-icu-telemedicine/Medxy AIzh2026-08-10T18:33:30-07:00住院 Medicare 按服务收费受益人远程医疗重症监护计费：2018—2024 年的趋势、影响因素及启示 https://news.medxy.ai/ja/telemedicine-icsu-trends/Medxy AIja2026-08-10T18:33:14-07:00入院Medicare受給者における遠隔医療集中治療の請求動向：2018年から2024年までの推移・規定因子・示唆 https://news.medxy.ai/vi/remote-medicare-care/Medxy AIvi2026-08-10T18:32:54-07:00Thanh toán chăm sóc tích cực từ xa ở người bệnh Medicare nội trú thanh toán theo dịch vụ: Xu hướng, yếu tố liên quan và hàm ý giai đoạn 2018–2024 https://news.medxy.ai/telemedicine-critical-care-billing-among-hospitalized-medicare-fee-for-service-beneficiaries-trends-determinants-and-implications-from-2018-to-2024/Medxy AIen2026-08-10T18:31:30-07:00Telemedicine Critical Care Billing Among Hospitalized Medicare Fee-For-Service Beneficiaries: Trends, Determinants, and Implications from 2018 to 2024 https://news.medxy.ai/zh/postoperative-delirium-impact/Medxy AIzh2026-08-10T18:30:12-07:00术后谵妄与再住院、认知下降之间的关系：老年患者研究解析 https://news.medxy.ai/ja/postoperative-delirium-cognitive-decline/Medxy AIja2026-08-10T18:29:55-07:00術後せん妄はなぜ認知機能低下につながるのか――再入院との関連を検証 https://news.medxy.ai/vi/postoperative-delirium-elderly/Medxy AIvi2026-08-10T18:29:39-07:00Giải mã mối liên hệ giữa rối loạn tri giác sau phẫu thuật, tái nhập viện và suy giảm nhận thức ở người cao tuổi https://news.medxy.ai/deciphering-the-link-between-postoperative-delirium-rehospitalization-and-cognitive-decline-in-older-adults/Medxy AIen2026-08-10T18:28:42-07:00Deciphering the Link Between Postoperative Delirium, Rehospitalization, and Cognitive Decline in Older Adults https://news.medxy.ai/zh/economic-impact-measles-2025/Medxy AIzh2026-08-10T18:27:31-07:002025年新墨西哥州麻疹暴发的经济影响：凸显预防未来暴发的成本 https://news.medxy.ai/economic-impact-of-the-2025-new-mexico-measles-outbreak-highlighting-the-cost-of-efforts-to-prevent-future-outbreaks/Medxy AIen2026-08-10T18:25:44-07:00Economic Impact of the 2025 New Mexico Measles Outbreak: Highlighting the Cost of Efforts to Prevent Future Outbreaks https://news.medxy.ai/zh/haploidentical-transplant-preconditioning/Medxy AIzh2026-08-10T18:24:20-07:00单倍型相合移植中全身照射与化疗预处理之比较：EBMT登记研究对首次缓解期AML患者的启示 https://news.medxy.ai/ja/aml-transplant-comparison/Medxy AIja2026-08-10T18:24:01-07:00初回寛解期AMLに対する半合致移植における全身放射線照射と化学療法前処置の比較：EBMTレジストリからの知見 https://news.medxy.ai/vi/total-body-irradiation-vs-conditioning-aml/Medxy AIvi2026-08-10T18:23:40-07:00So sánh chiếu xạ toàn thân và điều kiện hóa hóa trị trong ghép nửa hòa hợp cho bệnh nhân AML ở lần lui bệnh đầu tiên: Dữ liệu từ sổ đăng ký EBMT https://news.medxy.ai/comparing-total-body-irradiation-and-chemotherapy-conditioning-in-haploidentical-transplants-for-aml-patients-in-first-remission-insights-from-the-ebmt-registry/Medxy AIen2026-08-10T18:22:18-07:00Comparing Total Body Irradiation and Chemotherapy Conditioning in Haploidentical Transplants for AML Patients in First Remission: Insights from the EBMT Registry https://news.medxy.ai/zh/pembrolizumab-radiotherapy-potential/Medxy AIzh2026-08-10T18:21:01-07:00帕博利珠单抗联合放疗在晚期皮肤 T 细胞淋巴瘤中展现潜力：英国 NCRI Ⅱ期试验最终结果 https://news.medxy.ai/ja/pembrolizumab-radiation-skin-lymphoma/Medxy AIja2026-08-10T18:20:46-07:00進行皮膚T細胞リンパ腫におけるpembrolizumab併用放射線療法の可能性：英国NCRI第II相試験の最終結果 https://news.medxy.ai/vi/pembrolizumab-radiation-lymphoma/Medxy AIvi2026-08-10T18:20:26-07:00Pembrolizumab phối hợp xạ trị cho thấy triển vọng trong u lympho tế bào T ở da tiến xa: Kết quả cuối cùng từ thử nghiệm giai đoạn II UK NCRI https://news.medxy.ai/pembrolizumab-combined-with-radiotherapy-shows-promise-in-advanced-cutaneous-t-cell-lymphoma-final-results-from-uk-ncri-phase-ii-trial/Medxy AIen2026-08-10T18:19:05-07:00Pembrolizumab Combined with Radiotherapy Shows Promise in Advanced Cutaneous T-Cell Lymphoma: Final Results from UK NCRI Phase II Trial https://news.medxy.ai/zh/atelis-syndrome-causes/Medxy AIzh2026-08-10T18:16:31-07:00揭示Atelis Syndrome的病因：SLF2与SMC5功能异常驱动造血干细胞老化及骨髓增生异常综合征易感性 https://news.medxy.ai/ja/atelis-syndrome-overview/Medxy AIja2026-08-10T18:16:12-07:00Atelis症候群の全貌：SLF2・SMC5異常が引き起こす造血幹細胞老化と骨髄異形成症候群素因 https://news.medxy.ai/vi/slf2-and-smc5-dysfunction-as-drivers-of-hematopoietic-stem-cell-aging-and-myelodysplastic-syndrome-predisposition/Medxy AIvi2026-08-10T18:15:53-07:00Hội chứng Atelis: Rối loạn chức năng SLF2 và SMC5 là tác nhân thúc đẩy quá trình lão hóa tế bào gốc tạo máu và nguy cơ mắc hội chứng rối loạn sinh tủy https://news.medxy.ai/unveiling-atelis-syndrome-slf2-and-smc5-dysfunction-as-drivers-of-hematopoietic-stem-cell-aging-and-myelodysplastic-syndrome-predisposition/Medxy AIen2026-08-10T18:14:57-07:00Unveiling Atelis Syndrome: SLF2 and SMC5 Dysfunction as Drivers of Hematopoietic Stem Cell Aging and Myelodysplastic Syndrome Predisposition https://news.medxy.ai/zh/raas-inhibitors-sickle-cell-anemia/Medxy AIzh2026-08-10T18:13:35-07:00RAAS 抑制剂会加重镰状细胞病贫血：临床与机制新认识 https://news.medxy.ai/ja/sickle-cell-raas-inhibitors/Medxy AIja2026-08-10T18:13:15-07:00鎌状赤血球病におけるRAAS阻害薬は貧血を悪化させる：臨床的・機序的考察 https://news.medxy.ai/vi/renin-angiotensin-inhibitors-sickle-cell/Medxy AIvi2026-08-10T18:12:55-07:00Thuốc ức chế hệ renin-angiotensin-aldosterone làm nặng thiếu máu trong bệnh hồng cầu hình liềm: Những hiểu biết lâm sàng và cơ chế https://news.medxy.ai/renin-angiotensin-aldosterone-system-inhibitors-worsen-anemia-in-sickle-cell-disease-clinical-and-mechanistic-insights/Medxy AIen2026-08-10T18:11:48-07:00Renin-Angiotensin-Aldosterone System Inhibitors Worsen Anemia in Sickle Cell Disease: Clinical and Mechanistic Insights https://news.medxy.ai/ultrasound-guided-brachiocephalic-venipuncture-for-neonatal-central-venous-access-a-multicenter-study-validating-safety-and-feasibility/Medxy AIen2026-08-10T18:09:35-07:00Ultrasound-Guided Brachiocephalic Venipuncture for Neonatal Central Venous Access: A Multicenter Study Validating Safety and Feasibility https://news.medxy.ai/zh/texas-abortion-impact/Medxy AIzh2026-08-10T18:08:15-07:00德州堕胎禁令对住院孕妇重症结局的影响：一项回顾性队列分析 https://news.medxy.ai/ja/texas-abortion-impact-2/Medxy AIja2026-08-10T18:07:57-07:00テキサス州の中絶禁止は入院妊婦の重篤疾患にどう影響したか：後ろ向きコホート解析 https://news.medxy.ai/vi/texas-abortion-ban-impact/Medxy AIvi2026-08-10T18:07:34-07:00Tác động của lệnh cấm phá thai tại Texas đối với bệnh nặng nguy kịch ở phụ nữ mang thai nhập viện: Phân tích đoàn hệ hồi cứu https://news.medxy.ai/impact-of-texas-abortion-ban-on-critical-illness-in-hospitalized-pregnant-women-a-retrospective-cohort-analysis/Medxy AIen2026-08-10T18:06:20-07:00Impact of Texas Abortion Ban on Critical Illness in Hospitalized Pregnant Women: A Retrospective Cohort Analysis